S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SXTPW 60 Degrees Pharmaceuticals Inc

0.056002

0.0008 (1.45%)

Apr 25 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

60 Degrees Pharmaceuticals (NASDAQ:SXTPW)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals (NASDAQ:SXTPW)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals Inc News

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey
Tuesday 22 April 2025 (4 days ago) • GlobeNewswire Inc.

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21
Thursday 10 April 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 9 April 2025 (2 weeks ago) • Edgar (US Regulatory)

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
Tuesday 8 April 2025 (3 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 2 April 2025 (3 weeks ago) • Edgar (US Regulatory)

60 Degrees Pharmaceuticals Announces 2024 Annual Results
Friday 28 March 2025 (4 weeks ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Thursday 27 March 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 27 March 2025 (4 weeks ago) • Edgar (US Regulatory)

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
Thursday 20 February 2025 (2 months ago) • GlobeNewswire Inc.

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
Tuesday 11 February 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 6 February 2025 (3 months ago) • Edgar (US Regulatory)

60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Thursday 6 February 2025 (3 months ago) • GlobeNewswire Inc.

More 60 Degrees Pharmaceuticals Inc News Articles

Code Green Apparel (PK)

Seafarer Exploration (PK)

Halozyme Therapeutics

Bounce Mobile Systems (PK)

VeeMost Technologies (PK)

Accredited Solutions (PK)

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Elite Pharmaceuticals (QB)

Liquidmetal Technologies (QB)

Voip Pal Com (QB)

UAV Corpoation (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions